1. Acknowledgement to Referees

   Acknowledgement to Referees 19 October 2011 Article: 139

2. New oral antidiabetic agents

   • Paolo Cavallo Perin
   • Paolo Fornengo

   WARD MEDICINE 19 October 2011 Article: 135

   

3. Critical limb ischemia

   • Paolo Gresele
   • Chiara Busti
   • Tiziana Fierro

   WARD MEDICINE 19 October 2011 Article: 129

4. Chronic granulomatous disease

   • Lorenzo Loffredo

   WARD MEDICINE 19 October 2011 Article: 125

   

5. Non-neurological complications of acute stroke: frequency and influence on clinical outcome

   • Andrea Alberti
   • Giancarlo Agnelli
   • Maurizio Paciaroni

   WARD MEDICINE 19 October 2011 Article: 119

6. Cancer in the elderly

   • Silvio Monfardini
   • Cristina Falci
   • Umberto Basso

   WARD MEDICINE 19 October 2011 Article: 115

7. Aortic stiffness, blood pressure and renal dysfunction

   • Davide Grassi
   • Claudio Ferri

   MEET THE EXPERT 19 October 2011 Article: 111

8. The difficulties of Polytherapy: examples from antimicrobial chemotherapy

   • Teresita Mazzei

   Meet the Expert 19 October 2011 Article: 103

9. Cardiovascular injury in systemic autoimmune diseases: an update

   • Maurizio Turiel
   • Piercarlo Sarzi-Puttini
   • Livio Tomasoni

   MEET THE EXPERT 19 October 2011 Article: 99

   

10. From liver cirrhosis to HCC

    • Luigi Bolondi
    • Laura Gramantieri

    MEET THE EXPERT 19 October 2011 Article: 93

11. Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit

    • Giuseppe Realdi
    • Sandro Giannini
    • Franco Tosato

    LECTURE 19 October 2011 Article: 85

    

12. Management of patients with chronic kidney disease

    • Francesco P. Schena

    SELECTED PAPERS - SUBCLINICAL RENAL INSUFFICIENCY 19 October 2011 Article: 77

13. Chronic kidney disease epidemic: myth and reality

    • Filippo Mangione
    • Antonio Dal Canton

    SELECTED PAPERS - SUBCLINICAL RENAL INSUFFICIENCY 19 October 2011 Article: 69

    

14. Residual cardiovascular risk in secondary prevention

    • Alberto Zambon

    SYMPOSIUM – WHAT INTERVENTION TRIALS DON’T TELL US: THE RESIDUAL RISK 19 October 2011 Article: 61

    

15. What intervention trials don’t tell us: the residual risk in primary prevention

    • Claudio Cimminiello

    SYMPOSIUM – WHAT INTERVENTION TRIALS DON’T TELL US: THE RESIDUAL RISK 19 October 2011 Article: 53

    

16. The epidemiological concept of residual risk

    • Diego Vanuzzo

    SYMPOSIUM – WHAT INTERVENTION TRIALS DON’T TELL US: THE RESIDUAL RISK 19 October 2011 Article: 45

    

17. Effects of supplementation with polyunsaturated fatty acids in patients with heart failure

    • Savina Nodari
    • Marco Triggiani
    • Livio Dei Cas

    SYMPOSIUM – METABOLIC THERAPY: NEW OPPORTUNITY FOR TREATMENT OF HEART FAILURE 19 October 2011 Article: 37

    

18. Salt and water imbalance in chronic heart failure

    • Gaspare Parrinello
    • Daniele Torres
    • Salvatore Paterna

    SYMPOSIUM – METABOLIC THERAPY: NEW OPPORTUNITY FOR TREATMENT OF HEARTH FAILURE 19 October 2011 Article: 29

19. Optimal use and cost-effectiveness of biologic therapies in inflammatory bowel disease

    • Antonio Di Sabatino
    • Lucio Liberato
    • Gino R. Corazza

    SYMPOSIUM – BIOLOGICAL THERAPIES: NEW INDICATIONS, CLINICAL AND PHARMACO-ECONOMIC ASSESSMENT 19 October 2011 Article: 17

    

20. Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA)

    • Gianfranco Ferraccioli
    • Elisa Gremese

    SYMPOSIUM – BIOLOGICAL THERAPIES: NEW INDICATIONS, CLINICAL AND PHARMACO-ECONOMIC ASSESSMENT 19 October 2011 Article: 11

    

21. New indications for biological therapies

    • Mariagrazia Catanoso
    • Nicolò Pipitone
    • Carlo Salvarani

    SYMPOSIUM – BIOLOGICAL THERAPIES: NEW INDICATIONS, CLINICAL AND PHARMACO-ECONOMIC ASSESSMENT 19 October 2011 Article: 1